AMPHOTERICIN LIPOSOMAL RAN amphotericin B (amphotericin) 50mg powder for injection vial
देश: ऑस्ट्रेलिया
भाषा: अंग्रेज़ी
स्रोत: Department of Health (Therapeutic Goods Administration)
सार्वजनिक आकलन रिपोर्ट
(PAR)
15-03-2023
अनुरोध भेजा।
सक्रिय संघटक:
amphotericin B, Quantity: 50 mg
थमां उपलब्ध:
Sun Pharma ANZ Pty Ltd
फार्मास्यूटिकल फॉर्म:
Injection, powder for
रचना:
Excipient Ingredients: cholesterol; sodium succinate hexahydrate; dl-alpha-tocopherol; sucrose; hydrogenated soy phosphatidylcholine; sodium hydroxide; hydrochloric acid; 1,2-distearoyl-sn-glycero-3-phospho-(1'-rac-glycerol) sodium
प्रशासन का मार्ग:
Intravenous Infusion
पैकेज में यूनिट:
10 x vials + 10x 5 micrometre sterile filters, Single vial and single 5 micrometre sterile filter
प्रिस्क्रिप्शन प्रकार:
(S4) Prescription Only Medicine
चिकित्सीय संकेत:
AMPHOTERICIN LIPOSOMAL RAN is indicated for:,? prophylaxis in liver transplant patients at risk of systemic Candida, Aspergillus and Cryptococcus infections, and for,? the treatment of systemic fungal infections caused by organisms susceptible to Amphotericin B (See section 5.1 PHARMACODYNAMIC PROPERTIES, Clinical Trials).,AMPHOTERICIN LIPOSOMAL RAN is indicated for empirical treatment of presumed fungal infections in febrile neutropaenic patients whose fever has failed to respond to broad spectrum antibiotic treatment.,AMPHOTERICIN LIPOSOMAL RAN is indicated for the treatment of visceral leishmaniasis. Clinical studies of efficacy in visceral leishmaniasis are limited to Leishmania infantum.
उत्पाद समीक्षा:
Visual Identification: Yellow coloured lyophilized mass or powder; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
प्राधिकरण का दर्जा:
Registered
प्राधिकरण की तारीख:
2023-03-15
